Ingevity (NGVT) Financials

$39.16 +3.65 (+10.26%)

Closing price 03:59 PM Eastern

Extended Trading

$39.17 +0.01 (+0.03%)

As of 04:33 PM Eastern

Annual Income Statements for Ingevity

This table shows Ingevity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	129	80	35	127	169	184	181	118	212	-5.40	-430
Consolidated Net Income / (Loss)	133	84	44	145	182	184	181	118	212	-5.40	-430
Net Income / (Loss) Continuing Operations	133	84	44	145	182	184	181	118	212	-5.40	-430
Total Pre-Tax Income	202	137	87	175	222	228	235	163	270	-10	-536
Total Operating Income	216	156	102	191	253	271	273	290	324	83	-276
Total Gross Profit	319	275	274	329	417	482	466	513	570	472	455
Total Revenue	1,036	958	908	972	1,134	1,293	1,216	1,392	1,668	1,692	1,406
Operating Revenue	1,036	958	908	972	1,134	1,293	1,216	1,392	1,668	1,692	1,406
Total Cost of Revenue	717	683	634	643	717	811	751	879	1,098	1,220	952
Operating Cost of Revenue	717	683	634	643	717	811	751	879	1,098	1,220	952
Total Operating Expenses	103	120	173	138	164	212	192	222	246	389	730
Selling, General & Admin Expense	108	110	114	106	132	163	149	179	199	184	167
Research & Development Expense	-	17	18	20	22	20	23	26	30	32	28
Impairment Charge	-	-	-	-	-	-	-	-	0.00	0.00	349
Restructuring Charge	-5.60	-7.50	41	11	10	27	20	17	5.00	174	187
Total Other Income / (Expense), net	-14	-19	-15	-16	-31	-43	-38	-128	-54	-93	-260
Interest Expense	16	20	19	18	33	55	47	52	62	93	98
Interest & Investment Income	-	0.00	1.40	2.30	3.40	7.70	4.90	4.00	7.50	6.30	7.70
Other Income / (Expense), net	2.50	1.00	3.20	-0.50	-1.00	4.30	4.10	-80	-	-5.70	-170
Income Tax Expense	70	52	43	30	40	44	54	45	58	-4.70	-105
Basic Earnings per Share	$3.06	$1.89	$0.83	$3.00	$4.02	$4.39	$4.39	$2.97	$5.54	($0.15)	($11.85)
Weighted Average Basic Shares Outstanding	-	42.10M	42.11M	42.13M	42.04M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M
Diluted Earnings per Share	$3.06	$1.89	$0.83	$2.97	$3.97	$4.35	$4.37	$2.95	$5.50	($0.15)	($11.85)
Weighted Average Diluted Shares Outstanding	-	42.10M	42.11M	42.13M	42.04M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M
Weighted Average Basic & Diluted Shares Outstanding	-	42.10M	42.11M	42.13M	42.04M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M

This table shows Ingevity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	75	16	51	36	25	-117	-56	-284	-107	17
Consolidated Net Income / (Loss)	75	16	51	36	25	-117	-56	-284	-107	17
Net Income / (Loss) Continuing Operations	75	16	51	36	25	-117	-56	-284	-107	17
Total Pre-Tax Income	96	20	64	48	32	-154	-72	-335	-138	8.80
Total Operating Income	109	38	66	69	57	-109	-17	-311	-2.30	55
Total Gross Profit	176	105	130	153	129	60	100	123	130	102
Total Revenue	482	384	393	482	446	372	340	391	377	299
Operating Revenue	482	384	393	482	446	372	340	391	377	299
Total Cost of Revenue	306	278	262	329	317	312	240	267	247	197
Operating Cost of Revenue	306	278	262	329	317	312	240	267	247	197
Total Operating Expenses	67	68	65	84	73	168	117	435	132	47
Selling, General & Admin Expense	54	56	49	52	40	43	47	41	39	39
Research & Development Expense	7.60	7.20	8.80	8.00	7.80	7.20	6.80	7.30	6.70	7.30
Restructuring Charge	1.90	3.10	1.90	21	25	126	0.30	13	87	87
Total Other Income / (Expense), net	-14	-18	-1.40	-22	-24	-45	-55	-23	-136	-47
Interest & Investment Income	-12	45	-20	-22	-23	71	-22	-23	-24	77
Income Tax Expense	20	4.10	13	12	6.90	-37	-16	-51	-31	-7.80
Basic Earnings per Share	$1.99	$0.44	$1.36	$0.98	$0.70	($3.19)	($1.54)	($7.81)	($2.95)	$0.45
Weighted Average Basic Shares Outstanding	37.37M	37.15M	36.33M	36.22M	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M
Diluted Earnings per Share	$1.98	$0.43	$1.35	$0.97	$0.69	($3.16)	($1.54)	($7.81)	($2.95)	$0.45
Weighted Average Diluted Shares Outstanding	37.37M	37.15M	36.33M	36.22M	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M
Weighted Average Basic & Diluted Shares Outstanding	37.37M	37.15M	36.33M	36.22M	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	8.40	9.90	-1.90	41	-10	-13	194	20	-196	28	-25
Net Cash From Operating Activities	139	72	128	174	252	276	352	293	313	205	129
Net Cash From Continuing Operating Activities	139	72	128	157	252	276	352	293	313	205	129
Net Income / (Loss) Continuing Operations	133	84	44	145	182	184	181	118	212	-5.40	-430
Consolidated Net Income / (Loss)	133	84	44	145	182	184	181	118	212	-5.40	-430
Depreciation Expense	32	35	39	40	57	85	100	110	109	123	108
Non-Cash Adjustments To Reconcile Net Income	-4.80	-2.80	53	1.90	34	50	31	149	78	307	585
Changes in Operating Assets and Liabilities, net	-22	-44	-2.30	-19	-14	-43	47	-84	-85	-219	-135
Net Cash From Investing Activities	-97	-89	-126	-59	-414	-658	-111	-139	-552	-77	-80
Net Cash From Continuing Investing Activities	-97	-89	-126	-59	-414	-658	-111	-139	-552	-77	-80
Purchase of Property, Plant & Equipment	-102	-101	-57	-53	-94	-115	-82	-104	-143	-110	-78
Acquisitions	-	-	-	0.00	-316	-538	0.00	-35	-345	0.00	0.00
Purchase of Investments	-	0.00	-70	-4.00	-2.00	-	-	-	-77	-2.40	-0.30
Sale and/or Maturity of Investments	0.00	0.00	0.00	1.00	1.10	-	0.00	0.00	15	32	0.00
Other Investing Activities, net	-1.00	0.60	0.00	-3.00	-4.10	-5.60	-29	0.50	-2.20	3.40	-1.60
Net Cash From Financing Activities	-32	27	-3.40	-58	154	369	-50	-133	48	-100	-70
Net Cash From Continuing Financing Activities	-32	27	-3.40	-58	154	369	-50	-133	48	-100	-70
Repayment of Debt	0.00	-5.80	-13	-270	-7.10	-789	-882	-25	-972	-383	-471
Repurchase of Common Equity	-	0.00	0.00	-6.60	-47	-6.40	-88	-109	-145	-92	0.00
Issuance of Debt	2.80	7.10	412	231	304	1,175	896	0.00	1,165	376	405
Other Financing Activities, net	-31	29	52	-0.70	-0.40	-10	24	1.60	1.00	-0.80	-4.10
Effect of Exchange Rate Changes	-1.60	-	-	-	-1.40	0.20	2.20	-1.70	-6.00	-0.30	-4.20
Cash Interest Paid	6.50	6.50	15	16	26	48	40	48	55	83	85
Cash Income Taxes Paid	0.00	1.40	22	62	35	15	47	54	55	30	27

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-59	6.90	1.80	-9.20	17	18	-6.80	20	28	-67
Net Cash From Operating Activities	100	99	5.30	48	105	46	-12	30	47	65
Net Cash From Continuing Operating Activities	100	99	5.30	48	105	46	-12	30	47	65
Net Income / (Loss) Continuing Operations	75	16	51	36	25	-117	-56	-284	-107	17
Consolidated Net Income / (Loss)	75	16	51	36	25	-117	-56	-284	-107	17
Depreciation Expense	26	30	31	30	31	31	30	27	26	25
Non-Cash Adjustments To Reconcile Net Income	14	28	22	51	76	158	83	367	152	-16
Changes in Operating Assets and Liabilities, net	-15	25	-98	-68	-26	-26	-68	-81	-25	39
Net Cash From Investing Activities	-86	-407	2.50	-23	-32	-25	-16	-18	-17	-28
Net Cash From Continuing Investing Activities	-86	-407	2.50	-23	-32	-25	-16	-18	-17	-28
Purchase of Property, Plant & Equipment	-36	-49	-25	-22	-34	-29	-17	-18	-18	-25
Purchase of Investments	-	-15	-	-	-	-	-	-	-	-0.30
Other Investing Activities, net	-1.90	1.10	-3.50	-1.10	3.50	4.50	0.30	0.30	0.60	-2.80
Net Cash From Financing Activities	-72	313	-5.60	-35	-53	-6.50	23	10	-6.30	-98
Net Cash From Continuing Financing Activities	-72	313	-5.60	-35	-53	-6.50	23	10	-6.30	-98
Repayment of Debt	-23	-59	-60	-85	-95	-143	-55	-20	-44	-351
Issuance of Debt	-	377	90	108	42	137	81	31	38	254
Other Financing Activities, net	0.70	0.80	-2.20	1.20	0.30	-0.10	-3.00	-0.40	-0.40	-0.30
Effect of Exchange Rate Changes	-1.40	2.60	-0.40	-0.30	-2.30	2.70	-1.80	-2.00	5.40	-5.80
Cash Interest Paid	7.20	19	15	25	18	25	17	25	19	24
Cash Income Taxes Paid	16	12	4.70	19	4.30	1.80	2.90	19	1.80	2.90

This table presents Ingevity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	779	833	930	1,315	2,142	2,335	2,469	2,737	2,623	2,023
Total Current Assets	296	295	369	423	463	629	725	683	659	493
Cash & Equivalents	32	31	88	78	57	258	275	77	96	68
Accounts Receivable	95	90	100	119	150	-	-	225	-	141
Inventories, net	149	151	160	191	213	189	241	335	309	227
Prepaid Expenses	20	24	21	35	44	34	47	47	72	57
Plant, Property, & Equipment, net	438	423	439	524	0.00	0.00	0.00	799	762	659
Total Noncurrent Assets	45	115	122	369	1,679	1,706	1,744	1,255	1,203	871
Goodwill	12	12	12	131	436	445	442	519	528	175
Intangible Assets	10	7.30	4.90	126	396	373	338	405	336	279
Noncurrent Deferred & Refundable Income Taxes	0.00	3.40	3.40	2.90	5.00	8.10	6.80	5.70	12	118
Other Noncurrent Operating Assets	23	92	102	110	841	879	958	326	327	299
Total Liabilities & Shareholders' Equity	779	833	930	1,315	2,142	2,335	2,469	2,737	2,623	2,023
Total Liabilities	261	698	652	977	1,611	1,692	1,795	2,038	1,992	1,827
Total Current Liabilities	100	137	153	183	216	223	269	304	363	264
Short-Term Debt	9.40	7.50	9.40	11	23	26	20	0.90	84	61
Accounts Payable	65	79	83	93	99	104	126	175	158	95
Accrued Expenses	15	19	20	37	33	47	52	54	72	58
Current Deferred & Payable Income Tax Liabilities	0.80	5.30	1.50	0.50	15	5.30	6.20	3.60	9.20	5.60
Current Employee Benefit Liabilities	10	26	39	42	28	25	48	53	20	28
Other Current Liabilities	-	-	-	0.00	17	16	17	17	19	17
Total Noncurrent Liabilities	162	561	499	793	1,395	1,469	1,526	1,735	1,629	1,563
Long-Term Debt	80	481	444	741	1,228	1,267	1,250	1,473	1,383	1,340
Noncurrent Deferred & Payable Income Tax Liabilities	74	70	41	37	100	117	115	107	71	56
Other Noncurrent Operating Liabilities	7.20	10	13	15	67	85	162	156	175	167
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Equity & Noncontrolling Interests	517	135	278	339	531	642	674	698	631	195
Total Preferred & Common Equity	514	127	264	339	531	642	674	698	631	195
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	514	127	264	339	531	642	674	698	631	195
Common Stock	0.00	130	141	99	113	122	137	153	165	177
Retained Earnings	0.00	16	143	314	497	678	796	1,008	1,002	572
Treasury Stock	0.00	-0.30	-7.70	-56	-75	-162	-272	-416	-510	-513
Accumulated Other Comprehensive Income / (Loss)	-17	-19	-12	-18	-5.00	4.70	13	-47	-27	-41

This table presents Ingevity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	2,335	2,772	2,828	2,767	2,567	2,276	2,212
Total Current Assets	645	716	764	735	669	686	637
Cash & Equivalents	72	78	68	85	89	107	136
Accounts Receivable	-	240	260	217	191	213	190
Inventories, net	282	361	387	387	326	302	261
Prepaid Expenses	43	37	50	47	64	63	50
Plant, Property, & Equipment, net	721	805	801	800	727	722	671
Total Noncurrent Assets	970	1,251	1,263	1,232	1,171	868	904
Goodwill	388	522	527	520	526	177	187
Intangible Assets	272	399	394	376	303	296	299
Noncurrent Deferred & Refundable Income Taxes	6.90	7.40	7.00	6.10	24	81	114
Other Noncurrent Operating Assets	303	323	335	331	319	315	304
Total Liabilities & Shareholders' Equity	2,335	2,772	2,828	2,767	2,567	2,276	2,212
Total Liabilities	1,702	2,047	2,114	2,048	1,999	1,991	1,997
Total Current Liabilities	290	279	311	305	352	358	361
Short-Term Debt	0.90	0.90	0.90	3.00	85	103	101
Accounts Payable	165	174	204	197	153	142	97
Accrued Expenses	57	55	64	65	71	70	117
Current Deferred & Payable Income Tax Liabilities	6.80	11	5.10	5.40	8.00	2.70	4.70
Current Employee Benefit Liabilities	45	22	20	17	17	21	24
Other Current Liabilities	16	16	18	18	19	19	18
Total Noncurrent Liabilities	1,411	1,768	1,803	1,743	1,647	1,634	1,636
Long-Term Debt	1,153	1,503	1,526	1,470	1,409	1,401	1,398
Noncurrent Deferred & Payable Income Tax Liabilities	107	108	110	105	64	62	66
Other Noncurrent Operating Liabilities	151	158	168	168	174	171	173
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	634	726	714	719	568	285	215
Total Preferred & Common Equity	634	726	714	719	568	285	215
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	634	726	714	719	568	285	215
Common Stock	148	159	164	163	170	172	175
Retained Earnings	992	1,058	1,094	1,119	946	663	555
Treasury Stock	-411	-453	-510	-510	-512	-512	-513
Accumulated Other Comprehensive Income / (Loss)	-95	-39	-34	-54	-36	-38	-3.50

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-7.46%	-5.22%	7.06%	16.58%	14.05%	-5.94%	14.42%	19.89%	1.43%	-16.88%
EBITDA Growth	0.00%	-23.76%	-27.93%	72.06%	27.20%	19.30%	2.97%	-13.52%	35.05%	-53.85%	-268.85%
EBIT Growth	0.00%	-28.33%	-33.01%	81.70%	32.00%	9.22%	0.91%	-24.09%	53.87%	-76.26%	-679.32%
NOPAT Growth	0.00%	-32.19%	-45.99%	205.84%	30.43%	5.31%	-3.32%	-0.06%	20.67%	-77.26%	-433.78%
Net Income Growth	0.00%	-36.43%	-47.33%	227.03%	25.21%	1.05%	-1.25%	-34.90%	79.17%	-102.55%	-7,868.52%
EPS Growth	0.00%	-38.24%	-56.08%	257.83%	33.67%	9.57%	0.46%	-32.49%	86.44%	-102.73%	-7,800.00%
Operating Cash Flow Growth	0.00%	-47.87%	77.15%	36.28%	44.58%	9.40%	27.82%	-16.77%	6.85%	-34.56%	-37.30%
Free Cash Flow Firm Growth	0.00%	0.00%	107.06%	220.22%	-250.73%	-202.51%	152.31%	-14.61%	-178.37%	186.88%	87.52%
Invested Capital Growth	0.00%	0.00%	3.15%	8.52%	57.54%	70.21%	-2.75%	-0.58%	25.60%	-4.41%	-23.69%
Revenue Q/Q Growth	0.00%	0.00%	1.17%	1.95%	4.53%	1.96%	1.86%	0.75%	2.94%	-0.70%	-4.93%
EBITDA Q/Q Growth	0.00%	0.00%	-5.62%	12.37%	1.62%	6.77%	2.55%	-8.43%	-2.06%	-42.88%	-3.44%
EBIT Q/Q Growth	0.00%	0.00%	-3.41%	11.99%	5.18%	5.41%	4.96%	-12.84%	-3.31%	-66.17%	-1.30%
NOPAT Q/Q Growth	0.00%	0.00%	10.28%	33.38%	-3.67%	1.27%	0.16%	-5.53%	-2.82%	-67.23%	37.31%
Net Income Q/Q Growth	0.00%	0.00%	8.29%	33.33%	-3.14%	1.21%	0.95%	-12.39%	-6.08%	-104.25%	23.67%
EPS Q/Q Growth	0.00%	0.00%	295.24%	6.83%	0.51%	1.64%	1.16%	-10.61%	-5.66%	-104.36%	23.35%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	15.02%	-6.99%	21.68%	-0.04%	23.82%	-20.79%	7.62%	-20.32%	16.59%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-14.11%	10.53%	-8.40%	45.91%	-24.55%	-188.66%	169.90%	26.96%
Invested Capital Q/Q Growth	0.00%	0.00%	-4.95%	4.31%	-0.05%	2.40%	-2.35%	1.15%	22.11%	-4.95%	-3.11%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.76%	28.74%	30.21%	33.83%	36.77%	37.28%	38.28%	36.85%	34.17%	27.89%	32.33%
EBITDA Margin	24.22%	19.95%	15.17%	24.38%	26.61%	27.83%	30.47%	23.03%	25.94%	11.80%	-23.98%
Operating Margin	20.86%	16.24%	11.20%	19.65%	22.28%	20.92%	22.47%	20.87%	19.42%	4.88%	-19.60%
EBIT Margin	21.10%	16.34%	11.55%	19.60%	22.19%	21.25%	22.80%	15.13%	19.42%	4.54%	-31.68%
Profit (Net Income) Margin	12.81%	8.80%	4.89%	14.93%	16.04%	14.21%	14.92%	8.49%	12.68%	-0.32%	-30.60%
Tax Burden Percent	65.61%	61.76%	51.03%	83.07%	81.97%	80.61%	77.16%	72.54%	78.49%	53.47%	80.34%
Interest Burden Percent	92.49%	87.16%	82.94%	91.71%	88.16%	82.93%	84.78%	77.34%	83.24%	-13.13%	120.22%
Effective Tax Rate	34.39%	38.24%	48.97%	16.93%	18.03%	19.39%	22.84%	27.46%	21.51%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	33.44%	8.89%	25.68%	24.99%	15.92%	12.39%	12.59%	13.51%	2.82%	-10.93%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-7.66%	5.98%	22.39%	20.14%	12.25%	9.75%	3.47%	9.95%	-1.75%	-28.48%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-0.85%	4.73%	44.72%	33.98%	26.33%	18.54%	5.36%	17.33%	-3.63%	-93.18%
Return on Equity (ROE)	0.00%	32.59%	13.62%	70.40%	58.97%	42.25%	30.93%	17.95%	30.84%	-0.81%	-104.11%
Cash Return on Invested Capital (CROIC)	0.00%	-166.56%	5.79%	17.51%	-19.69%	-36.04%	15.17%	13.18%	-9.18%	7.33%	15.95%
Operating Return on Assets (OROA)	0.00%	20.11%	13.02%	21.63%	22.42%	15.90%	12.39%	8.76%	12.44%	2.87%	-19.18%
Return on Assets (ROA)	0.00%	10.83%	5.51%	16.48%	16.20%	10.63%	8.11%	4.92%	8.13%	-0.20%	-18.52%
Return on Common Equity (ROCE)	0.00%	32.35%	13.38%	66.71%	57.63%	42.25%	30.93%	17.95%	30.84%	-0.81%	-104.11%
Return on Equity Simple (ROE_SIMPLE)	0.00%	16.41%	34.96%	55.02%	53.68%	34.61%	28.25%	17.53%	30.30%	-0.86%	-220.44%
Net Operating Profit after Tax (NOPAT)	142	96	52	159	207	218	211	211	254	58	-193
NOPAT Margin	13.69%	10.03%	5.71%	16.32%	18.26%	16.86%	17.33%	15.14%	15.24%	3.42%	-13.72%
Net Nonoperating Expense Percent (NNEP)	0.00%	41.10%	2.91%	3.29%	4.85%	3.67%	2.64%	9.12%	3.57%	4.57%	17.55%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	11.71%	2.76%	-12.09%
Cost of Revenue to Revenue	69.24%	71.26%	69.79%	66.17%	63.23%	62.72%	61.72%	63.15%	65.83%	72.11%	67.67%
SG&A Expenses to Revenue	10.44%	11.47%	12.54%	10.94%	11.68%	12.62%	12.29%	12.89%	11.92%	10.86%	11.85%
R&D to Revenue	0.00%	1.82%	1.94%	2.04%	1.90%	1.52%	1.86%	1.89%	1.82%	1.88%	2.00%
Operating Expenses to Revenue	9.90%	12.50%	19.01%	14.18%	14.48%	16.36%	15.81%	15.98%	14.76%	23.01%	51.93%
Earnings before Interest and Taxes (EBIT)	219	157	105	191	252	275	277	211	324	77	-446
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	251	191	138	237	302	360	371	320	433	200	-337
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	18.19	11.25	10.37	6.89	4.87	4.18	3.77	2.71	7.59
Price to Tangible Book Value (P/TBV)	0.00	0.00	21.53	12.04	42.63	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	2.54	3.05	3.10	2.83	2.57	2.02	1.58	1.01	1.05
Price to Earnings (P/E)	0.00	0.00	65.64	23.46	20.77	19.89	17.23	23.85	12.44	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	1.52%	4.26%	4.81%	5.03%	5.80%	4.19%	8.04%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	4.68	5.20	4.13	2.81	2.48	2.28	1.92	1.54	1.84
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	3.06	3.44	3.69	3.75	3.42	2.74	2.42	1.82	2.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	20.15	14.12	13.88	13.48	11.23	11.89	9.31	15.43	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	26.47	17.56	16.64	17.65	15.01	18.10	12.44	40.08	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	53.49	21.09	20.22	22.24	19.74	18.09	15.85	53.31	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	21.71	19.20	16.62	17.59	11.81	12.99	12.86	15.03	21.88
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	82.14	30.93	0.00	0.00	16.12	17.29	0.00	20.53	10.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.17	3.63	1.63	2.22	2.36	2.01	1.88	2.11	2.32	7.18
Long-Term Debt to Equity	0.00	0.15	3.58	1.60	2.19	2.31	1.97	1.86	2.11	2.19	6.86
Financial Leverage	0.00	0.11	0.79	2.00	1.69	2.15	1.90	1.54	1.74	2.08	3.27
Leverage Ratio	0.00	1.51	2.47	4.27	3.64	3.98	3.82	3.65	3.79	4.03	5.62
Compound Leverage Factor	0.00	1.31	2.05	3.92	3.21	3.30	3.24	2.82	3.16	-0.53	6.76
Debt to Total Capital	0.00%	14.73%	78.41%	62.00%	68.96%	70.21%	66.83%	65.33%	67.85%	69.91%	87.77%
Short-Term Debt to Total Capital	0.00%	1.55%	1.20%	1.29%	1.03%	1.26%	1.34%	1.01%	0.04%	4.02%	3.84%
Long-Term Debt to Total Capital	0.00%	13.18%	77.21%	60.71%	67.93%	68.95%	65.48%	64.32%	67.80%	65.89%	83.93%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.63%	1.22%	1.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	84.64%	20.37%	36.09%	31.04%	29.79%	33.17%	34.67%	32.15%	30.09%	12.23%
Debt to EBITDA	0.00	0.47	3.55	1.91	2.49	3.48	3.49	3.96	3.41	7.35	-4.15
Net Debt to EBITDA	0.00	0.30	3.33	1.54	2.24	3.32	2.80	3.10	3.23	6.87	-3.95
Long-Term Debt to EBITDA	0.00	0.42	3.49	1.87	2.46	3.41	3.42	3.90	3.40	6.92	-3.97
Debt to NOPAT	0.00	0.93	9.42	2.86	3.63	5.74	6.14	6.03	5.80	25.38	-7.26
Net Debt to NOPAT	0.00	0.60	8.83	2.30	3.26	5.48	4.91	4.72	5.49	23.72	-6.91
Long-Term Debt to NOPAT	0.00	0.83	9.27	2.80	3.58	5.63	6.01	5.93	5.79	23.92	-6.94
Altman Z-Score	0.00	0.00	3.75	4.95	4.20	2.85	2.64	2.46	2.46	1.93	0.99
Noncontrolling Interest Sharing Ratio	0.00%	0.73%	1.75%	5.24%	2.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	2.97	2.16	2.41	2.31	2.15	2.81	2.70	2.25	1.81	1.87
Quick Ratio	0.00	1.27	0.88	1.23	1.07	0.96	1.82	1.63	0.99	0.77	0.79
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-479	34	108	-163	-494	258	220	-173	150	282
Operating Cash Flow to CapEx	136.05%	71.56%	225.57%	331.37%	268.37%	240.16%	429.23%	282.56%	219.93%	186.79%	165.72%
Free Cash Flow to Firm to Interest Expense	0.00	-23.82	1.75	5.98	-4.91	-9.04	5.48	4.26	-2.80	1.61	2.88
Operating Cash Flow to Interest Expense	8.45	3.59	6.63	9.63	7.59	5.05	7.48	5.67	5.07	2.20	1.31
Operating Cash Flow Less CapEx to Interest Expense	2.24	-1.43	3.69	6.72	4.76	2.95	5.74	3.67	2.77	1.02	0.52
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.23	1.13	1.10	1.01	0.75	0.54	0.58	0.64	0.63	0.61
Accounts Receivable Turnover	0.00	10.07	9.82	10.25	10.36	9.62	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	4.59	4.22	4.14	4.08	4.02	3.74	4.09	3.81	3.79	3.55
Fixed Asset Turnover	0.00	2.19	2.11	2.26	2.36	0.00	0.00	0.00	0.00	2.17	1.98
Accounts Payable Turnover	0.00	10.54	8.80	7.93	8.15	8.45	7.38	7.64	7.31	7.32	7.53
Days Sales Outstanding (DSO)	0.00	36.26	37.17	35.62	35.24	37.96	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	79.58	86.40	88.27	89.47	90.90	97.62	89.35	95.75	96.29	102.71
Days Payable Outstanding (DPO)	0.00	34.63	41.46	46.04	44.81	43.21	49.43	47.77	49.95	49.84	48.50
Cash Conversion Cycle (CCC)	0.00	81.21	82.11	77.86	79.90	85.65	48.19	41.58	45.80	46.46	54.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	575	593	643	1,014	1,725	1,678	1,668	2,095	2,003	1,528
Invested Capital Turnover	0.00	3.33	1.56	1.57	1.37	0.94	0.71	0.83	0.89	0.83	0.80
Increase / (Decrease) in Invested Capital	0.00	575	18	51	370	712	-47	-9.80	427	-92	-475
Enterprise Value (EV)	0.00	0.00	2,776	3,347	4,187	4,849	4,162	3,811	4,029	3,082	2,814
Market Capitalization	0.00	0.00	2,310	2,968	3,512	3,655	3,126	2,817	2,632	1,711	1,481
Book Value per Share	$0.00	$12.20	$3.02	$6.27	$8.07	$12.69	$15.55	$17.15	$18.69	$17.43	$5.37
Tangible Book Value per Share	$0.00	$11.68	$2.55	$5.86	$1.96	($7.22)	($4.28)	($2.69)	($6.02)	($6.41)	($7.12)
Total Capital	0.00	607	623	731	1,091	1,782	1,936	1,943	2,172	2,099	1,596
Total Debt	0.00	89	489	453	752	1,251	1,293	1,270	1,473	1,467	1,401
Total Long-Term Debt	0.00	80	481	444	741	1,228	1,267	1,250	1,473	1,383	1,340
Net Debt	0.00	57	458	366	675	1,194	1,036	994	1,397	1,371	1,333
Capital Expenditures (CapEx)	102	101	57	53	94	115	82	104	143	110	78
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	174	135	137	173	214	174	200	304	284	222
Debt-free Net Working Capital (DFNWC)	0.00	206	166	225	251	270	431	476	381	380	290
Net Working Capital (NWC)	0.00	197	158	216	239	248	405	456	380	296	229
Net Nonoperating Expense (NNE)	9.12	12	7.50	14	25	34	29	93	43	63	237
Net Nonoperating Obligations (NNO)	0.00	57	458	366	675	1,194	1,036	994	1,397	1,371	1,333
Total Depreciation and Amortization (D&A)	32	35	33	47	50	85	93	110	109	123	108
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	18.15%	14.90%	14.09%	15.27%	16.53%	14.28%	14.39%	18.22%	16.80%	15.81%
Debt-free Net Working Capital to Revenue	0.00%	21.49%	18.25%	23.13%	22.11%	20.90%	35.47%	34.18%	22.82%	22.46%	20.65%
Net Working Capital to Revenue	0.00%	20.51%	17.43%	22.16%	21.12%	19.16%	33.33%	32.77%	22.77%	17.48%	16.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.06	$1.89	$0.83	$3.00	$4.02	$4.39	$4.39	$2.97	$5.54	($0.15)	($11.85)
Adjusted Weighted Average Basic Shares Outstanding	0.00	42.10M	42.13M	42.08M	41.62M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M
Adjusted Diluted Earnings per Share	$3.06	$1.89	$0.83	$2.97	$3.97	$4.35	$4.37	$2.95	$5.50	($0.15)	($11.85)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	42.10M	42.13M	42.08M	41.62M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	42.10M	42.13M	42.08M	41.62M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M
Normalized Net Operating Profit after Tax (NOPAT)	138	91	73	168	215	240	226	223	258	179	182
Normalized NOPAT Margin	13.33%	9.54%	8.03%	17.25%	19.01%	18.54%	18.62%	16.02%	15.47%	10.61%	12.94%
Pre Tax Income Margin	19.52%	14.24%	9.58%	17.98%	19.57%	17.63%	19.33%	11.70%	16.16%	-0.60%	-38.08%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.32	7.79	5.44	10.53	7.58	5.03	5.89	4.07	5.24	0.82	-4.56
NOPAT to Interest Expense	8.64	4.78	2.69	8.77	6.24	3.99	4.48	4.07	4.11	0.62	-1.97
EBIT Less CapEx to Interest Expense	7.12	2.77	2.50	7.62	4.75	2.93	4.14	2.06	2.94	-0.35	-5.35
NOPAT Less CapEx to Interest Expense	2.43	-0.24	-0.25	5.86	3.41	1.89	2.73	2.07	1.81	-0.56	-2.77
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	2.34%	4.03%	1,022.30%	8.47%	52.42%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	2.34%	4.03%	1,022.30%	13.02%	78.49%	3.48%	48.51%	92.63%	68.62%	-1,705.56%	0.00%

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	27.92%	14.17%	2.56%	14.74%	-7.47%	-3.10%	-13.37%	-18.93%	-15.49%	-19.61%
EBITDA Growth	340.40%	-10.66%	-0.52%	-15.08%	-35.49%	-214.87%	-117.42%	-384.95%	-202.45%	203.33%
EBIT Growth	4,026.92%	-21.13%	-5.21%	-24.35%	-48.56%	-388.33%	-159.26%	-549.35%	-306.70%	150.97%
NOPAT Growth	40.93%	-19.77%	-23.91%	-26.69%	-48.44%	-354.88%	-123.51%	-522.64%	-103.63%	237.34%
Net Income Growth	1,895.24%	-46.76%	-16.61%	-40.64%	-66.58%	-848.72%	-210.45%	-899.15%	-525.40%	114.21%
EPS Growth	1,900.00%	-43.42%	-12.90%	-37.01%	-65.15%	-834.88%	-214.07%	-905.15%	-527.54%	114.24%
Operating Cash Flow Growth	0.00%	29.10%	-78.19%	-46.52%	5.09%	-53.10%	-328.30%	-38.64%	-55.80%	39.61%
Free Cash Flow Firm Growth	-85.16%	-944.81%	-918.55%	-505.99%	-1,894.77%	104.08%	144.76%	164.90%	252.23%	3,471.90%
Invested Capital Growth	4.04%	25.60%	24.44%	27.79%	22.80%	-4.41%	-8.28%	-22.61%	-25.14%	-23.69%
Revenue Q/Q Growth	14.79%	-20.41%	2.35%	22.72%	-7.43%	-16.66%	-8.50%	14.85%	-3.51%	-20.72%
EBITDA Q/Q Growth	13.29%	-48.95%	71.60%	-13.15%	-13.94%	-190.91%	76.08%	-1,320.50%	69.06%	191.70%
EBIT Q/Q Growth	17.14%	-64.86%	128.07%	-17.20%	-20.35%	-296.92%	54.37%	-527.82%	63.36%	148.55%
NOPAT Q/Q Growth	22.28%	-65.30%	81.73%	-0.45%	-14.00%	-271.55%	83.99%	-1,689.66%	99.26%	6,590.97%
Net Income Q/Q Growth	26.09%	-79.31%	225.00%	-29.98%	-29.01%	-563.49%	52.05%	-406.61%	62.21%	115.49%
EPS Q/Q Growth	28.57%	-78.28%	213.95%	-28.15%	-28.87%	-557.97%	51.27%	-407.14%	62.23%	115.25%
Operating Cash Flow Q/Q Growth	10.61%	-1.60%	-94.62%	813.21%	117.36%	-56.08%	-127.13%	345.45%	56.57%	38.71%
Free Cash Flow Firm Q/Q Growth	-81.36%	-2,155.06%	6.98%	-13.52%	17.58%	104.67%	923.57%	64.61%	93.32%	9.66%
Invested Capital Q/Q Growth	0.92%	22.11%	2.68%	0.99%	-3.02%	-4.95%	-1.48%	-14.78%	-6.19%	-3.11%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.58%	27.48%	33.21%	31.76%	28.92%	16.01%	29.31%	31.54%	34.47%	34.10%
EBITDA Margin	27.59%	17.70%	29.24%	20.69%	19.24%	-20.98%	-5.88%	-72.73%	-23.32%	26.97%
Operating Margin	22.68%	9.83%	16.68%	14.38%	12.67%	-29.24%	-5.12%	-79.72%	-0.61%	18.54%
EBIT Margin	22.26%	9.83%	21.32%	14.38%	12.38%	-29.24%	-14.58%	-79.72%	-30.27%	18.54%
Profit (Net Income) Margin	15.64%	4.07%	12.91%	7.37%	5.65%	-31.42%	-16.47%	-72.63%	-28.44%	5.56%
Tax Burden Percent	78.71%	79.19%	79.10%	74.42%	78.50%	75.84%	77.89%	84.79%	77.74%	188.64%
Interest Burden Percent	89.28%	52.25%	76.58%	68.83%	58.15%	141.67%	144.96%	107.45%	120.86%	15.88%
Effective Tax Rate	21.29%	20.81%	20.90%	25.58%	21.50%	0.00%	0.00%	0.00%	0.00%	-88.64%
Return on Invested Capital (ROIC)	17.19%	6.90%	11.41%	9.62%	8.87%	-16.91%	-2.85%	-44.84%	-0.34%	27.86%
ROIC Less NNEP Spread (ROIC-NNEP)	16.18%	5.71%	11.33%	8.34%	7.32%	-19.85%	-5.94%	-49.45%	-8.02%	21.36%
Return on Net Nonoperating Assets (RNNOA)	26.40%	9.95%	19.80%	15.25%	13.36%	-41.32%	-13.00%	-141.33%	-23.64%	69.88%
Return on Equity (ROE)	43.59%	16.85%	31.21%	24.87%	22.23%	-58.22%	-15.85%	-186.17%	-23.98%	97.75%
Cash Return on Invested Capital (CROIC)	11.58%	-9.18%	-9.58%	-13.12%	-11.24%	7.33%	8.63%	11.65%	12.04%	15.95%
Operating Return on Assets (OROA)	15.15%	6.30%	13.69%	9.64%	8.27%	-18.46%	-8.96%	-48.37%	-17.99%	11.23%
Return on Assets (ROA)	10.65%	2.61%	8.29%	4.94%	3.77%	-19.84%	-10.11%	-44.06%	-16.90%	3.36%
Return on Common Equity (ROCE)	43.59%	16.85%	31.21%	24.87%	22.23%	-58.22%	-15.85%	-186.17%	-23.98%	97.75%
Return on Equity Simple (ROE_SIMPLE)	35.54%	0.00%	27.77%	24.81%	17.67%	0.00%	-19.73%	-151.44%	-262.80%	0.00%
Net Operating Profit after Tax (NOPAT)	86	30	52	52	44	-76	-12	-218	-1.61	105
NOPAT Margin	17.85%	7.78%	13.20%	10.70%	9.95%	-20.47%	-3.58%	-55.81%	-0.43%	34.97%
Net Nonoperating Expense Percent (NNEP)	1.02%	1.19%	0.09%	1.28%	1.55%	2.94%	3.10%	4.60%	7.68%	6.50%
Return On Investment Capital (ROIC_SIMPLE)	-	1.37%	-	-	-	-3.63%	-	-	-	6.55%
Cost of Revenue to Revenue	63.42%	72.52%	66.79%	68.24%	71.08%	83.99%	70.69%	68.46%	65.53%	65.90%
SG&A Expenses to Revenue	11.24%	14.57%	12.38%	10.73%	8.97%	11.68%	13.88%	10.60%	10.27%	13.19%
R&D to Revenue	1.58%	1.88%	2.24%	1.66%	1.75%	1.94%	2.00%	1.87%	1.78%	2.44%
Operating Expenses to Revenue	13.90%	17.65%	16.53%	17.37%	16.26%	45.25%	34.43%	111.26%	35.08%	15.56%
Earnings before Interest and Taxes (EBIT)	107	38	84	69	55	-109	-50	-311	-114	55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	133	68	115	100	86	-78	-20	-284	-88	81
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.64	3.77	3.66	2.96	2.40	2.71	3.04	5.58	6.61	7.59
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.42	1.58	1.58	1.21	1.01	1.01	1.05	1.03	0.96	1.05
Price to Earnings (P/E)	10.24	12.44	13.19	11.92	13.58	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	9.77%	8.04%	7.58%	8.39%	7.36%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.98	1.92	1.90	1.64	1.48	1.54	1.59	1.78	1.76	1.84
Enterprise Value to Revenue (EV/Rev)	2.09	2.42	2.43	2.05	1.83	1.82	1.91	1.93	1.88	2.00
Enterprise Value to EBITDA (EV/EBITDA)	7.67	9.31	9.45	8.98	8.90	15.43	48.28	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	10.12	12.44	12.79	12.75	13.69	40.08	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	12.95	15.85	17.25	16.36	17.64	53.31	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.64	12.86	13.87	14.16	12.09	15.03	16.69	17.66	25.21	21.88
Enterprise Value to Free Cash Flow (EV/FCFF)	17.39	0.00	0.00	0.00	0.00	20.53	17.61	13.30	12.54	10.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.82	2.11	2.07	2.14	2.05	2.32	2.63	5.28	6.99	7.18
Long-Term Debt to Equity	1.82	2.11	2.07	2.14	2.04	2.19	2.48	4.92	6.52	6.86
Financial Leverage	1.63	1.74	1.75	1.83	1.83	2.08	2.19	2.86	2.95	3.27
Leverage Ratio	3.72	3.79	3.70	3.80	3.77	4.03	4.13	5.11	5.33	5.62
Compound Leverage Factor	3.33	1.98	2.84	2.61	2.19	5.71	5.98	5.49	6.45	0.89
Debt to Total Capital	64.55%	67.85%	67.44%	68.13%	67.20%	69.91%	72.44%	84.08%	87.48%	87.77%
Short-Term Debt to Total Capital	0.05%	0.04%	0.04%	0.04%	0.14%	4.02%	4.11%	5.76%	5.88%	3.84%
Long-Term Debt to Total Capital	64.50%	67.80%	67.40%	68.09%	67.07%	65.89%	68.33%	78.32%	81.60%	83.93%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	35.45%	32.15%	32.56%	31.87%	32.80%	30.09%	27.56%	15.92%	12.52%	12.23%
Debt to EBITDA	2.61	3.41	3.48	3.84	4.21	7.35	23.01	-5.72	-4.60	-4.15
Net Debt to EBITDA	2.45	3.23	3.30	3.67	3.97	6.87	21.65	-5.31	-4.18	-3.95
Long-Term Debt to EBITDA	2.61	3.40	3.48	3.84	4.20	6.92	21.71	-5.33	-4.29	-3.97
Debt to NOPAT	4.41	5.80	6.35	6.99	8.35	25.38	-7,111.43	-5.64	-4.87	-7.26
Net Debt to NOPAT	4.14	5.49	6.02	6.68	7.87	23.72	-6,690.00	-5.24	-4.43	-6.91
Long-Term Debt to NOPAT	4.41	5.79	6.35	6.99	8.33	23.92	-6,708.10	-5.25	-4.54	-6.94
Altman Z-Score	2.44	2.11	2.21	2.03	1.94	1.69	1.76	1.29	1.43	1.80
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.22	2.25	2.57	2.46	2.41	1.81	1.90	1.92	1.77	1.87
Quick Ratio	1.10	0.99	1.14	1.05	0.99	0.77	0.80	0.90	0.90	0.79
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	19	-397	-371	-421	-347	16	166	273	528	579
Operating Cash Flow to CapEx	277.29%	200.20%	20.87%	223.04%	314.03%	158.22%	-72.89%	164.09%	258.33%	259.04%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.68	0.64	0.64	0.67	0.67	0.63	0.61	0.61	0.59	0.61
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	7.60	6.55	7.28	0.00
Inventory Turnover	4.12	3.81	3.59	3.54	3.55	3.79	3.49	3.30	3.29	3.55
Fixed Asset Turnover	2.28	0.00	2.20	0.00	2.24	2.17	2.14	2.03	2.01	1.98
Accounts Payable Turnover	7.20	7.31	7.37	6.32	6.56	7.32	7.33	6.57	7.26	7.53
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	48.05	55.76	50.15	0.00
Days Inventory Outstanding (DIO)	88.58	95.75	101.71	103.16	102.85	96.29	104.61	110.61	110.78	102.71
Days Payable Outstanding (DPO)	50.70	49.95	49.54	57.77	55.68	49.84	49.80	55.54	50.25	48.50
Cash Conversion Cycle (CCC)	37.87	45.80	52.16	45.39	47.17	46.46	102.86	110.83	110.68	54.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,716	2,095	2,151	2,173	2,107	2,003	1,973	1,681	1,577	1,528
Invested Capital Turnover	0.96	0.89	0.87	0.90	0.89	0.83	0.80	0.80	0.80	0.80
Increase / (Decrease) in Invested Capital	67	427	423	472	391	-92	-178	-491	-530	-475
Enterprise Value (EV)	3,389	4,029	4,083	3,571	3,113	3,082	3,133	2,985	2,780	2,814
Market Capitalization	2,307	2,632	2,657	2,113	1,725	1,711	1,728	1,588	1,417	1,481
Book Value per Share	$16.66	$18.69	$19.53	$19.66	$19.84	$17.43	$15.64	$7.84	$5.90	$5.37
Tangible Book Value per Share	($0.68)	($6.02)	($5.25)	($5.70)	($4.89)	($6.41)	($7.17)	($5.17)	($7.46)	($7.12)
Total Capital	1,788	2,172	2,229	2,241	2,191	2,099	2,062	1,789	1,713	1,596
Total Debt	1,154	1,473	1,503	1,526	1,473	1,467	1,493	1,504	1,498	1,401
Total Long-Term Debt	1,153	1,473	1,503	1,526	1,470	1,383	1,409	1,401	1,398	1,340
Net Debt	1,082	1,397	1,426	1,458	1,388	1,371	1,405	1,397	1,363	1,333
Capital Expenditures (CapEx)	36	49	25	22	34	29	17	18	18	25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	283	304	361	386	348	284	314	324	241	222
Debt-free Net Working Capital (DFNWC)	356	381	438	454	432	380	402	431	377	290
Net Working Capital (NWC)	355	380	438	453	429	296	318	328	276	229
Net Nonoperating Expense (NNE)	11	14	1.11	16	19	41	44	66	106	88
Net Nonoperating Obligations (NNO)	1,082	1,397	1,426	1,458	1,388	1,371	1,405	1,397	1,363	1,333
Total Depreciation and Amortization (D&A)	26	30	31	30	31	31	30	27	26	25
Debt-free, Cash-free Net Working Capital to Revenue	17.49%	18.22%	21.48%	22.20%	20.42%	16.80%	19.13%	20.90%	16.31%	15.81%
Debt-free Net Working Capital to Revenue	21.95%	22.82%	26.12%	26.10%	25.38%	22.46%	24.53%	27.84%	25.46%	20.65%
Net Working Capital to Revenue	21.89%	22.77%	26.07%	26.05%	25.20%	17.48%	19.36%	21.18%	18.66%	16.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.99	$0.44	$1.36	$0.98	$0.70	($3.19)	($1.54)	($7.81)	($2.95)	$0.45
Adjusted Weighted Average Basic Shares Outstanding	37.37M	37.15M	36.33M	36.22M	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M
Adjusted Diluted Earnings per Share	$1.98	$0.43	$1.35	$0.97	$0.69	($3.16)	($1.54)	($7.81)	($2.95)	$0.45
Adjusted Weighted Average Diluted Shares Outstanding	37.37M	37.15M	36.33M	36.22M	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	37.37M	37.15M	36.33M	36.22M	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M
Normalized Net Operating Profit after Tax (NOPAT)	88	32	53	67	64	12	-12	35	59	99
Normalized NOPAT Margin	18.16%	8.42%	13.58%	13.95%	14.29%	3.30%	-3.52%	9.07%	15.69%	33.24%
Pre Tax Income Margin	19.88%	5.14%	16.33%	9.90%	7.20%	-41.43%	-21.14%	-85.66%	-36.59%	2.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	65.82%	68.62%	68.59%	83.18%	77.24%	-1,705.56%	-52.36%	0.00%	0.00%	0.00%

Frequently Asked Questions About Ingevity's Financials

When does Ingevity's fiscal year end?

According to the most recent income statement we have on file, Ingevity's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ingevity's net income changed over the last 10 years?

Ingevity's net income appears to be on a downward trend, with a most recent value of -$430.30 million in 2024, falling from $132.60 million in 2014. The previous period was -$5.40 million in 2023. See Ingevity's forecast for analyst expectations on what’s next for the company.

What is Ingevity's operating income?

Ingevity's total operating income in 2024 was -$275.70 million, based on the following breakdown:

Total Gross Profit: $454.70 million
Total Operating Expenses: $730.40 million

How has Ingevity revenue changed over the last 10 years?

Over the last 10 years, Ingevity's total revenue changed from $1.04 billion in 2014 to $1.41 billion in 2024, a change of 35.8%.

How much debt does Ingevity have?

Ingevity's total liabilities were at $1.83 billion at the end of 2024, a 8.3% decrease from 2023, and a 599.3% increase since 2015.

How much cash does Ingevity have?

In the past 9 years, Ingevity's cash and equivalents has ranged from $30.50 million in 2016 to $275.40 million in 2021, and is currently $68 million as of their latest financial filing in 2024.

How has Ingevity's book value per share changed over the last 10 years?

Over the last 10 years, Ingevity's book value per share changed from 0.00 in 2014 to 5.37 in 2024, a change of 537.0%.

Related Companies

This page (NYSE:NGVT) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ingevity (NGVT) Financials

Frequently Asked Questions About Ingevity's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ingevity (NGVT) Financials

Annual Income Statements for Ingevity

Quarterly Income Statements for Ingevity

Annual Cash Flow Statements for Ingevity

Quarterly Cash Flow Statements for Ingevity

Annual Balance Sheets for Ingevity

Quarterly Balance Sheets for Ingevity

Annual Metrics and Ratios for Ingevity

Quarterly Metrics and Ratios for Ingevity

Frequently Asked Questions About Ingevity's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools